1. Introduction {#sec1-molecules-24-00942}
===============

*Moringa oleifera*, a herb native to India \[[@B1-molecules-24-00942]\] which is also known as "miracle tree" or "the diamond in the plant", has been widely cultivated throughout the world for its multiple uses such as its being a source of nutrients and a medical herb \[[@B2-molecules-24-00942]\]. Most studies have focused on the leaves of the plant grown in India, Africa, or Madagascar \[[@B3-molecules-24-00942],[@B4-molecules-24-00942]\]. The *Moringa oleifera* leaf (ML) have been proven to have antioxidant \[[@B5-molecules-24-00942],[@B6-molecules-24-00942]\], anti-inflammatory \[[@B7-molecules-24-00942],[@B8-molecules-24-00942]\], anticancer \[[@B9-molecules-24-00942],[@B10-molecules-24-00942]\], anti-hypertensive \[[@B11-molecules-24-00942]\], hypolipidemic \[[@B12-molecules-24-00942]\], hypoglycemic \[[@B13-molecules-24-00942],[@B14-molecules-24-00942]\], antimicrobial \[[@B15-molecules-24-00942],[@B16-molecules-24-00942]\], and hepatoprotective \[[@B10-molecules-24-00942],[@B17-molecules-24-00942]\] pharmacological activities. It has also been reported that ML contains many phytoconstituents such as flavonoids, alkaloids, steroids, saponins, glucosinolates, tannis, phenolic acids, and terpenes, etc. \[[@B18-molecules-24-00942]\]. Certainly, its numerous pharmacological effects are due to the diversity of the phytochemicals in ML \[[@B19-molecules-24-00942]\].

In China, as a complement to medicinal plant resources, *Moringa oleifera* was introduced from India in the 1960s and had been cultivated on a large scale in Guangdong Province, Yunnan Province, and other areas since then \[[@B20-molecules-24-00942]\]. Additionally, ML was approved as a new food resource by the Chinese government in 2012 \[[@B21-molecules-24-00942]\]. In China, relative research on extraction, preparation, and activity evaluation has been carried out recently, and there have been some achievements \[[@B22-molecules-24-00942],[@B23-molecules-24-00942]\]. However, there has been a lack of profound research on the comprehensive screening and identification of the chemical constituents of ML grown in China. Furthermore, just as with other natural plants, *M. oleifera* ecotypes/cultivars differ from each other and can show many differences in leaf-mass production, growth performance, and secondary plant metabolite contents \[[@B24-molecules-24-00942],[@B25-molecules-24-00942]\]. Therefore, with an aim to evaluate the similarities and the differences between the chemical constituents of Chinese *Moringa oleifera* leaf (CML) and Indian *Moringa oleifera* leaf (IML), a comparative analysis of the phytochemical composition of these two kinds of ML was performed in this study. On one hand, a comprehensive screening analysis of chemical components may be conducted to evaluate the similarity of CML to IML. During this section, a combination of ultra-high-performance liquid chromatography (UPLC) separation, quadrupole time-of-flight tandem mass spectrometry (QTOF-MS) detection and a UNIFI platform automated data process would be applied \[[@B26-molecules-24-00942],[@B27-molecules-24-00942],[@B28-molecules-24-00942],[@B29-molecules-24-00942],[@B30-molecules-24-00942],[@B31-molecules-24-00942]\]. The accurate and specific mass could be provided by HR-MS when the coeluting constituents possess different *m*/*z* values. UNIFI might efficiently integrate data acquisition or mining and search libraries, and could generate reports using its comprehensive, simple, high throughput platform. The shared constituents of the Chinese and India *Moringa oleifera* leaves could be evaluated. On the other hand, with an aim to reveal the diversity of the metabolites, the untargeted metabolomics might be used to profile diverse classes of metabolites and compare the overall small-molecule metabolites of two kinds of samples \[[@B32-molecules-24-00942]\]. This means a combination of UPLC separation, QTOF-MS detection, and multivariate statistical analyses, such as principal component analysis (PCA) and orthogonal projections to latent structures discriminant analysis (OPLS-DA), would be used to profile these two leaves.

The study in this paper comparatively analyzes the chemical constituents of *Moringa oleifera* leaves in China and India for the first time and determines the similarities and differences between these two items. Our data might support further research and the exploration of potential applications in China.

2. Materials and Methods {#sec2-molecules-24-00942}
========================

2.1. Materials and Reagents {#sec2dot1-molecules-24-00942}
---------------------------

CML and IML were collected from their respective cultivation areas or purchased from herbal markets in China or India ([Table 1](#molecules-24-00942-t001){ref-type="table"}). The identity of the *Moringa oleifera* leaf was confirmed by the authors and the corresponding voucher specimens were deposited in the Research Center of Natural Drug, School of Pharmaceutical Sciences, Jilin University, China.

Methanol and acetonitrile (Fisher Chemical Company, USA) were used as they were suitable for UPLC-MS. Deionized water was purified using a Millipore water purification system (Millipore, Billerica, MA, USA). Formic acid for UPLC was purchased from the Sigma-Aldrich Company. All other chemicals were of analytical grade.

Standard compounds *α*-maltose, adenosine, catechin, chlorogenic acid, rutin, quercetin, kaempferol, caffeic acid, oleic acid, epicatechin, hyperoside, kaempferol-3-*O*-rutinoside, isorhamnetin, isorhamnetin-3-*O*-rutinoside, luteolin, scutellarein, methyl palmitate, ricinoleic acid, linolenic acid, dibutyl sebacate, eugenol, azelaic acid, (−)-epiafzelechin, methyl myristate, and 2′-hydroxygenistein were purchased from the National Institutes for Food and Drug Control (Beijing, China). Other reference compounds including parinaric acid, quinic acid, and 1,3-dicaffeoylquinic acid were purchased from Beijing Zhongke Quality Inspection Biotechnology Co., Ltd. (Beijing, China).

2.2. Sample Preparation and Extraction {#sec2dot2-molecules-24-00942}
--------------------------------------

Stalks were removed and the leaves air-dried, grinded, and sieved (Chinese National Standard Sieve No. 3, R40/3 series) to obtain a homogeneous powder. Then, the powder (1.0 g) was extracted with 80% methanol (1.0 L) at 80 °C thrice (for 3 h each time). After being filtered, the extraction solution was combined, concentrated, and evaporated to dryness. The desiccated extractions (all approximately 15 mg) were finally dissolved and diluted with 80% methanol 10.0 mL. The solution was filtered with a syringe filter (0.22 μm) and then injected into the UPLC system. Additionally, to ensure the suitability and stability consistency of MS analysis, a quality control (QC) sample was prepared by pooling the same volume (50 μL) from every sample. Through the whole worklist, 3 QC injections were performed randomly. The volume injected for the samples and QC was 2 μL for each run.

2.3. UPLC-QTOF-MS^E^ {#sec2dot3-molecules-24-00942}
--------------------

UPLC-QTOF-MS^E^ analysis was performed on a Waters Xevo G2-XS QTOF mass spectrometer (Waters Co., Milford, MA, USA) equipped with a UPLC system through an electrospray ionization (ESI) interface. Chromatographic separation was performed on an ACQUITY UPLC BEH C~18~ (100 mm × 2.1 mm, 1.7 μm) column provided by Waters Corporation. The mobile phases were composed of eluent A (0.1% formic acid in water, *v*/*v*) and eluent B (0.1% formic acid in acetonitrile, *v*/*v*) with flow rate of 0.4 mL/min. The elution conditions applied were: 0--2 min, 10% B; 2--26 min, 10--100% B; 26--29 min, 100% B; 29--29.1 min, 100--10% B; 29.1--32 min, 10% B. Mixtures of 90/10 and 10/90 water/acetonitrile were used as the weak wash solvent and the strong wash solvent, respectively. The temperatures of the column and autosampler were 30°C and 15 °C, respectively. The mass spectrum was acquired from 100 to 1500 Da in MS^E^ mode. The positive mode conditions were as follows: capillary voltage, 2.6 kV; source temperature, 150 °C; cone voltage, 40 V; cone gas flow, 50 L/h; desolvation temperature, 400 °C; desolvation gas flow, 800 L/h. Negative mode conditions were identical to the positive mode conditions except for the capillary voltage (2.2 kV). During a single LC run, data acquisition was performed via the mass spectrometer by rapidly switching from a low collision energy (CE) scan to a high-CE scan in MS^E^ mode. The collision energy of low energy function was set to 6 V while the ramp collision energy of high energy function was set to 20\~40 V. Leucine enkephalin (LE) (*m*/*z* 554.2615 in ESI^−^ mode and 556.2771 in ESI^+^ mode), the external reference of Lock Spray™, was infused at a constant flow of 10 μL/min. During acquisition, data were collected in continuum mode for the screening analysis and in centroid mode for the metabolomics analysis. Masslynx™ V4.1 workstation (Waters, Manchester, UK) was used to record the data.

2.4. Screening Analysis of Components of CML and IML by UNIFI Platform {#sec2dot4-molecules-24-00942}
----------------------------------------------------------------------

To quickly identify the chemical compounds, the MS raw data, compressed with Waters Compression and Archival Tool v1.10, was automatedly screened and identified using the streamlined workflow of UNIFI 1.7.0 software (Waters, Manchester, UK) \[[@B30-molecules-24-00942],[@B31-molecules-24-00942],[@B32-molecules-24-00942],[@B33-molecules-24-00942]\]. The parameters were as follows: for 2D peak detection, 200 was set as the minimum peak area; for 3D peak detection, the peak intensities of low energy and high energy were set as over 1000 and over 200 counts, respectively; mass error in the range of ±5 ppm was set for identified compounds; retention time in the range of ±0.1 min was allowed to match the reference substance. Generated predicted fragments from the structure were identified as the matching compounds. Negative adducts containing +COOH and -H and positive adducts containing +H and +Na were selected in the analysis. Leucine enkaplin was selected as the reference compound, and \[M − H\]^−^ 554.2620 was used for the negative ion and \[M + H\]^+^ 556.2766 for the positive ion. Components were further verified by comparing reference substances with retention time and by comparing characteristic MS fragmentation patterns in the literature. The chemical information database used for the components was as follows: besides the in-house Traditional Medicine Library in the Waters UNIFI platform, the investigation of chemical constituents was conducted systematically. A self-built database of compounds that were reported in ML was established by searching online databases or internet search engines such as PubMed, Full-Text Database (CNKI), ChemSpider, Web of Science, and Medline. Chemical information including the component name, structures of the components, and molecular formula were available from the database.

2.5. Metabonomics Analysis of CML and IML {#sec2dot5-molecules-24-00942}
-----------------------------------------

The raw data were processed for alignment, deconvolution, and data reduction, etc., with MarkerLynx XS V4.1 software (Waters, Milford, CT, USA) \[[@B34-molecules-24-00942]\]. A Markerlynx processing method was first created, and its main parameters included: retention time (RT) range 0\~26 min, minimum intensity 5%, mass range 100\~1500 Da, mass tolerance 0.10, mass window 0.10, marker intensity threshold 2000 counts, retention time window 0.20, and noise elimination level 6. After processing the data, the results were able to be shown in Extended Statistics (XS) Viewer. *m*/*z*-RT pairs with corresponding intensities for all the detected peaks from each data file were listed. The same values of RT and *m*/*z* in different batches of samples were regarded as the same component. Furthermore, multivariate statistical analysis was performed. Firstly, PCA was used to show the pattern recognition and maximum variation aiming to obtain the overview and classification. Secondly, OPLS-DA in ESI^+^ and ESI^−^ modes was performed in order to get the maximum separation between the CML and IML groups and to explore the potential chemical markers that contribute to the differences. Then, S-plots were created to provide visualization of the OPLS-DA predictive component loading to facilitate model interpretation. Meanwhile, the use of variable importance for the projection (VIP) was helpful in screening the different components, and metabolites with VIP value \> 1.0 and *p*-value below 0.05 were considered as potential markers \[[@B32-molecules-24-00942]\]. In addition, permutation testing was performed to provide reference distributions of the R^2^/Q^2^ values that could indicate statistical significance \[[@B35-molecules-24-00942],[@B36-molecules-24-00942]\]. Simca 15.0 software (Umetrics, Malmö, Sweden) was used to show the analysis results \[[@B33-molecules-24-00942],[@B35-molecules-24-00942]\].

3. Results {#sec3-molecules-24-00942}
==========

3.1. Identification of Components from CML and IML Based on the UNIFI Platform {#sec3dot1-molecules-24-00942}
------------------------------------------------------------------------------

As a result of screening analysis, a total of 122 compounds were identified or tentatively characterized in both ESI^+^ and ESI^−^ mode from CML and IML. There were 118 shared constituents identified in CML and IML. More specifically, 121 and 119 compounds were characterized from CML and IML, respectively ([Table 2](#molecules-24-00942-t002){ref-type="table"}). Both of the two types of *Moringa oleifera* leaves are rich in natural components with various structural patterns, including flavonoids, alkaloids, glyosides, organic acids and organic acid esters, iridoids, lignans, and steroids, etc. Base peak intensity (BPI) chromatograms marked with the number of compounds are shown in [Figure 1](#molecules-24-00942-f001){ref-type="fig"}. The chemical structures of the compounds are summarized in [Figure 2](#molecules-24-00942-f002){ref-type="fig"}.

3.2. Diversity Evaluation of CML and IML Using Metabolomics Analysis {#sec3dot2-molecules-24-00942}
--------------------------------------------------------------------

The QC injections were clustered tightly in PCA, indicating a satisfactory stability of the system. According to their common spectral characteristics, the PCA 2D plots of the samples from CML and IML groups were able to be easily classified within two clusters ([Figure 3](#molecules-24-00942-f003){ref-type="fig"}). The CML and IML samples were clearly separated, indicating that these two samples could be easily differentiated.

In order to evaluate the differences between the leaves in the two areas, OPLS-DA score plot, S-plot, permutation test, and variable importance in the projection values were obtained to understand which variables were responsible for this sample separation \[[@B72-molecules-24-00942]\]. After OPLS-DA plots ([Figure 4](#molecules-24-00942-f004){ref-type="fig"}a and [Figure 5](#molecules-24-00942-f005){ref-type="fig"}a) in both ESI^+^ and ESI^−^ modes were performed, the maximum separation between the CML and IML groups was available. With sufficient permutation testing, the lines of grouping samples were significantly located underneath the random sampling lines ([Figure 4](#molecules-24-00942-f004){ref-type="fig"}b and [Figure 5](#molecules-24-00942-f005){ref-type="fig"}b), which indicates a definite validity for the following characteristic metabolites biomarkers identification. S-plots were then created to explore the potential chemical markers that contributed to the differences. Based on *p* values (*p* \< 0.05) and VIP values (VIP \> 1) \[[@B26-molecules-24-00942],[@B30-molecules-24-00942]\] from univariate statistical analysis, 30 robust known chemical markers enabling differentiation between CML and IML were marked and listed ([Figure 4](#molecules-24-00942-f004){ref-type="fig"}c and [Figure 5](#molecules-24-00942-f005){ref-type="fig"}c and [Table 2](#molecules-24-00942-t002){ref-type="table"}). Additionally, a heatmap was generated from these chemical markers in order to systematically evaluate the markers ([Figure 6](#molecules-24-00942-f006){ref-type="fig"}), which visually showed the intensities of potential chemical markers between the two samples.

4. Discussion {#sec4-molecules-24-00942}
=============

Via the screening analysis, 121 and 119 compounds were characterized in CML and IML, respectively. As the results show, 93 compounds were identified in negative mode and 29 compounds were identified in positive mode. From the BPI chromatograms, it seems that the negative ionization mode was better than the positive mode based on the quantity and the responses of the identified compounds. However, it was still necessary to have run the positive mode because some compounds showed better responses in this mode than in the negative mode. The results also showed that both these ML areas are rich in natural components. It has been reported that there is high flavonoid content (presenting in flavanol and glycoside forms) in *M. oleifera* leaves \[[@B4-molecules-24-00942],[@B18-molecules-24-00942]\]. In this study, flavonoids were also the main chemical composition. Besides the most common flavonoids, 36 flavonoids, such as apigenin-8-C-glucoside, quercetin 3-*O*-*β*-[d]{.smallcaps}-glucopy-ranoside, kaempferol-7-*O*-α-[l]{.smallcaps}-rhamnoside, and 5, 7, 2′, 5′-tetrahydroxyflavone, were identified or tentatively characterized in *M. oleifera* leaves for the first time. Moreover, isothiocyanates have become a major topic of research interest regarding *Moringa* for their various biological activities \[[@B18-molecules-24-00942]\]. In our study, there were 4 isothiocyanates which were found both in IML and CML. A total of 118 compounds were shared constituents in CML and IML, which means that they were similar in terms of the kinds of compound contained. This comprehensive phytochemical profile study has revealed the structural diversity of secondary metabolites and the similar patterns within CML and IML.

Furthermore, in nontargeted metabolomic analysis, when taking the contents of the constituents into account, it was found that there indeed existed differences between CML and IML. Thirty robust known biomarkers enabling this differentiation were discovered. These are able to illustrate the differences between CML and IML and provide a basis for explaining the effect of different growth environments on secondary metabolites. With CML, there are 18 potential biomarkers, including seven flavonoids (14, 33, 55, 63, 74, 79, and 84), five organic acids and organic acid esters (30, 38, 80, 115, and 116), two glyosides (12 and 29), and four others (69, 93, 121, and 122). Among these biomarkers, compounds 14, 33, and 38 were detected only in CML under experimental conditions, and the others' contents in CML were greater than those in IML. Among these potential biomarkers, components 14, 33, 55, 74, 79, 30, and 80 were identified or tentatively characterized in *M. oleifera* leaves for the first time. It has been reported that *M. oleifera* leaves which originate from China have the maximum antioxidant activity when compared alongside those from Faisalabad, Multan, and India \[[@B73-molecules-24-00942]\]. As is known, biological activity is caused by the high contents of phytochemicals. Correlation studies between potential markers and biological activities should be performed in the future. For IML, there are 12 potential biomarkers, including six flavonoids (50, 51, 59, 62, 78, and 82), three organic acids and organic acid esters (81, 97, and 119), one glyoside (100), one alkaloid (104), and one lignan (60). Among these, compound 82 was detected only in IML under experimental conditions, and the other 11 compounds' contents were greater in IML than those in CML.

Based on the above results, it could be concluded that some of the secondary plant metabolite contents of CML and IML differ from each other. This is just as it is with other natural plants.

In summary, a total of 122 components, including 118 shared constituents, were characterized from CML and IML. For CML, 121 compounds were characterized, and among these, 18 potential biomarkers with higher contents enabled differentiation from IML. For IML, 119 compounds were characterized, and among these, 12 potential biomarkers with higher contents enabled differentiation from CML.

Even so, several unresolved issues still remain. For example, in the future, potential chemical markers' and identified compounds' pharmacological activities should be screened. In addition, there are still some unidentified components, despite 122 compounds being identified, as shown in the BPI chromatograms. Further research should be performed on these unknown components.

5. Conclusions {#sec5-molecules-24-00942}
==============

In this study, 121 and 119 chemical compounds, including 118 shared constituents, were respectively identified or tentatively characterized from CML and IML by combining UPLC-QTOF-MS and a UNIFI platform. Both CML and IML, which originate from two separate countries, are rich in phytochemicals and are similar in the kinds of compounds they contain. Moreover, a metabolomics study based on UPLC-QTOF-MS combined with multivariate statistical analysis has shown the significant differences in the contents of an amount of the compounds in these two accessions. A total of 30 robust known biomarkers enabling differentiation were discovered. For CML and IML, 18 and 12 potential biomarkers were identified, respectively. This study provides further data to make up for the deficient amount of study performed on the chemical constituents of *Moringa oleifera* leaves and can help with planning strategies focused on the proper utilization of this resource, as well as providing a reference for the further application of CML in China.
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![The representative base peak intensity (BPI) chromatograms of CML and IML in ESI^+^ and ESI^−^ modes, where ESI is electrospray ionization.](molecules-24-00942-g001){#molecules-24-00942-f001}

###### 

Chemical structures of compounds identified in CML and IML.
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![](molecules-24-00942-g002b)

![The principal component analysis (PCA) of CML and IML in ESI^+^ mode and ESI^−^ mode.](molecules-24-00942-g003){#molecules-24-00942-f003}

![Orthogonal partial least squares discriminant analysis (OPLS-DA) (**a**), permutation tests, (**b**) and S-plot (**c**) in ESI^−^ mode.](molecules-24-00942-g004){#molecules-24-00942-f004}

![OPLS-DA (**a**), permutation tests, (**b**) and S-plot (**c**) in ESI^+^ mode.](molecules-24-00942-g005){#molecules-24-00942-f005}

![Heatmap visualizing the intensities of potential chemical markers.](molecules-24-00942-g006){#molecules-24-00942-f006}

molecules-24-00942-t001_Table 1

###### 

The list of the tested samples from China and India. Legend: CML, Chinese *Moringa oleifera* leaf; IML, Indian *Moringa oleifera* leaf.

  Species   Sample No.   Source                                              Collection Time
  --------- ------------ --------------------------------------------------- -----------------
  CML       1            Pu'er City, Yunnan Province, China; market          November 2017
            2            Xishuangbanna City, Yunnan Province, China; field   March 2018
            3            Shaoguan City, Guangdong Province, China; market    January 2017
            4            Guangzhou City, Guangdong Province, China; field    December 2017
            5            Danzhou City, Hainan Province, China; market        January 2018
            6            Changjiang City, Hainan Province, China; market     March 2017
  IML       1            Howrah, India; market                               December 2017
            2            Howrah, India; market                               November 2017
            3            Tamil Nadu, India; market                           February 2018
            4            Tamil Nadu, India; market                           March 2018
            5            Maharastra, India; market                           January 2018
            6            Maharastra, India; market                           January 2017

molecules-24-00942-t002_Table 2

###### 

Compounds identified from CML and IML by ultra-high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry UPLC-QTOF-MS^E.^

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.        Retention Time (RT) (min)   Formula               Calculated Mass (Da)   Theoretical Mass (Da)   Mass Error (ppm)   MS^E^ Fragmentation                                                                                                                                                                                                   Identification                                                                                                Sources         Ref.
  ---------- --------------------------- --------------------- ---------------------- ----------------------- ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- --------------- -------------------------------
  1          0.59                        C~7~H~12~O~6~         192.0629               192.0634                −2.6               191.0542\[M − H\]^−^, 173.0432\[M-H-H~2~O\]^−^, 145.0516\[M-H-HCOOH\]^−^, 137.0232\[M-H-3H~2~O\]^−^, 127.0401\[M-H-H~2~O-HCOOH\]^−^                                                                                   Quinic acid                                                                                                   CML, IML        s

  2          0.60                        C~12~H~22~O~11~       342.1161               342.1162                −0.3               387.1143\[M + HCOO\]^−^, 179.0554\[M-H-Glu\]^−^                                                                                                                                                                       *α*-Maltose                                                                                                   CML, IML        s

  3          0.62                        C~16~H~18~O~9~        354.0968               354.0951                4.8                353.0895\[M − H\]^−^, 335.0896\[M-H-H~2~O\]^−^, 190.0544\[M-H-C~9~H~7~O~3~\]^−^, 190.0391\[M-H-3H~2~O-C~6~H~5~O~2~\]^−^, 143.0346\[M-H-HCOOH-C~9~H~8~O~3~\]^−^                                                        Cryptochlorogenic acid                                                                                        CML, IML        \[[@B37-molecules-24-00942]\]

  4          0.72                        C~10~H~13~N~5~O~4~    267.0968               267.0968                0.0                268.1041\[M + H\]^+^, 187.0620\[M + H-C~3~H~3~N~3~\]^+^, 161.0744\[M + H-C~4~H~3~N~4~\]^+^, 136.0612\[M + H-Rib\]^+^                                                                                                  Adenosine                                                                                                     CML, IML        s

  5          0.80                        C~13~H~16~O~8~        300.0836               300.0845                −2.9               299.0764\[M − H\]^−^, 178.0632\[M-H-C~7~H~5~O~2~\]^−^, 135.0231\[M-H-Glu\]^−^, 89.0347\[M-H-Glu-HCOOH\]^−^                                                                                                            Benzoic acid 4-*O*-*β*-glucoside                                                                              CML, IML        \[[@B18-molecules-24-00942]\]

  6          1.03                        C~20~H~29~NO~11~      459.1739               459.1741                −0.2               504.1721\[M + HCOO\]^−^, 427.1487\[M-H-NH~2~-CH~3~\]^−^, 307.0995\[M-H-C~8~H~9~NO~2~\]^−^, 279.1081\[M-H-Glu\]^−^, 150.0546\[M-H-2Glu\]^−^                                                                            3 ′′-*O*-*β-*[d]{.smallcaps}-glucopyranosyl derivatives (marumoside B)                                        CML, IML        \[[@B38-molecules-24-00942]\]

  7          1.04                        C~14~H~19~NO~6~       297.1210               297.1212                −0.7               342.1192\[M + HCOO\]^−^, 262.0758\[M-H-H~2~O-NH~2~\]^−^, 149.0546\[M-H-Rha\]^−^, 105.0430\[M-H-Rha-CONH~2~\]^−^                                                                                                       4 ′-Hydroxyphenylethanamide-*α-*[l]{.smallcaps}-rhamnopyranoside (marumoside A)                               CML, IML        \[[@B38-molecules-24-00942]\]

  8          1.18                        C~16~H~18~O~9~        354.0942               354.0951                −2.4               353.0869\[M − H\]^−^, 281.1169\[M-H-4H~2~O\]^−^, 190.0546\[M-H-C~9~H~7~O~3~\]^−^, 161.0285\[M-H-C~7~H~12~O~6~\]^−^, 134.0436\[M-H-C~8~H~11~O~7~\]^−^                                                                  Neochlorogenic acid                                                                                           CML, IML        \[[@B39-molecules-24-00942]\]

  9          1.38                        C~16~H~23~NO~7~       341.1458               341.1475                −4.7               342.1531\[M + H\]^+^, 261.1188\[M + H-2H~2~O-C~2~H~5~O\]^+^, 107.0492\[M + H-Rha-C~3~H~6~NO~2~\]^+^, 102.0550\[M + H-Rha-C~6~H~4~\]^+^                                                                                *O*-Ethyl-4-\[(*α*-[l]{.smallcaps}-rhamnosyloxy)-benzyl\]carbamate                                            CML, IML        \[[@B18-molecules-24-00942]\]

  10         1.47                        C~7~H~6~O~4~          154.0271               154.0266                3.2                153.0215\[M − H\]^−^, 135.0211\[M-H-H~2~O\]^−^, 89.0340\[M-H-H~2~O-HCOOH\]^−^                                                                                                                                         3,4-Dihydroxy-benzoic acid                                                                                    CML, IML        \[[@B40-molecules-24-00942]\]

  11         1.51                        C~13~H~16~O~7~        300.0892               300.0896                −1.5               299.0819\[M − H\]^−^, 160.0351\[M-H-H~2~O-C~7~H~5~O~2~\]^−^, 90.0343\[M-H-Glu-HCOOH\]^−^                                                                                                                              Benzaldehyde 4-*O-β*-glucoside                                                                                CML, IML        \[[@B41-molecules-24-00942]\]

  12 \*      1.70                        C~31~H~34~O~14~       630.1957               630.1949                1.3                675.1692\[M + HCOO\]^−^, 414.1127\[M-H-Ph-CH~3~-C~7~H~7~O~2~\]^−^, 353.0869\[M-H-H~2~O-C~7~H~6~O-C~8~H~8~O~3~\]^−^, 298.0797\[M-H-CH~3~-C~17~H~16~O~6~\]^−^, 222.0634\[M-H-Ph-Glu-C~8~H~7~O~3~\]^−^                   Mudanpioside J                                                                                                CML \>\> IML\   \[[@B42-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.73\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  13         1.71                        C~32~H~40~N~2~O~13~   660.2563               660.2530                4.6                705.2545\[M + HCOO\]^−^, 441.1367\[M-H-Rha-C~2~H~3~-C~2~H~4~\]^−^, 326.0797\[M-H-Rha-C~11~H~9~N~2~\]^−^, 263.0856\[M-H-Rha-Glu-C~4~H~5~\]^−^, 175.0444\[M-H-Rha-Glu-C~10~H~6~N\]^−^                                   N, *α*-[l]{.smallcaps}-Rhamnopyranosyl vincosamide                                                            CML, IML        \[[@B43-molecules-24-00942]\]

  14 \*      1.84                        C~15~H~12~O~7~        304.0573               304.0583                −3.2               349.00618\[M + HCOO\]^−^, 285.0418\[M-H-H~2~O\]^−^, 162.0364\[M-H-C~6~H~5~O~4~\]^−^, 152.9691\[M-H-CH~3~-C~8~H~8~O~2~\]^−^, 132.0231\[M-H-H~2~O-OCH~3~-C~7~H~6~O~2~\]^−^, 130.0235\[M-H-C~11~H~9~O~2~\]^−^            Dihydroquercetin                                                                                              CML\            \[[@B44-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 8.20\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  15         2.07                        C~16~H~18~O~9~        354.0951               354.0951                0.1                353.0878\[M − H\]^−^, 253.1035\[M-H-3H~2~O-HCOOH\]^−^, 190.0182\[M-H-3H~2~O-C~6~H~5~O~2~\]^−^, 144.0302\[M-H-H~2~O-C~7~H~11~O~6~\]^−^, 125.0251\[M-H-H~2~O-HCOOH-C~9~H~8~O~3~\]^−^                                    Chlorogenic acid                                                                                              CML, IML        s

  16         2.09                        C~17~H~20~O~9~        368.1102               368.1107                −1.5               367.1029\[M − H\]^−^, 336.0902\[M-H-OCH~3~\]^−^, 295.1124\[M-H-4H~2~O\]^−^, 243.0591\[M-H-CH~3~-C~6~H~5~O~2~\]^−^, 189.0549\[M-H-CH~3~-C~9~H~7~O~3~\]^−^, 178.0346\[M-H-C~8~H~13~O~5~\]^−^                            Methyl-3-caffeoylquinate                                                                                      CML, IML        \[[@B45-molecules-24-00942]\]

  17         2.34                        C~16~H~18~N~2~O~4~    302.1254               302.1267                −4.1               303.1327\[M + H\]^+^, 285.1232\[M + H-H~2~O\]^+^, 212.0983\[M + H-H~2~O-C~2~H~5~O~2~\]^+^, 176.0893\[M + H-2H~2~O-C~3~H~7~O~3~\]^+^                                                                                   Tangutorid E                                                                                                  CML, IML        \[[@B45-molecules-24-00942]\]

  18         2.35                        C~19~H~28~O~12~       448.1578               448.1581                −0.7               447.1505\[M − H\]^−^,417.0973\[M-H-2CH~3~\]^−^, 267.1031\[M-H-Glu\]^−^, 245.1016\[M-H-OCOCH~3~-C~6~H~7~O~4~\]^−^, 167.0480\[M-H-Glu-C~4~H~4~O~3~\]^−^                                                                 8-*O*-Acetylshanzhiside methyl ester                                                                          CML, IML        \[[@B46-molecules-24-00942]\]

  19         2.53                        C~9~H~8~O~4~          180.0414               180.0423                −4.5               179.0335\[M − H\]^−^, 143.0430\[M-H-2H~2~O\]^−^, 133.0433\[M-H-HCOOH\]^−^, 108.0265\[M-H-C~3~H~3~O~2~\]^−^                                                                                                            Caffeic acid                                                                                                  CML, IML        s

  20         2.62                        C~16~H~18~N~2~O~4~    302.1257               302.1267                −3.1               303.1330\[M + H\]^+^, 285.1248\[M + H-H~2~O\]^+^, 194.0881\[M + H-2H~2~O-C~2~H~5~O~2~\]^+^, 194.0895\[M + H-H~2~O-C~3~H~7~O~2~\]^+^, 118.0799\[M + H-H~2~O-C~11~H~7~N~2~\]^+^                                         Tangutorid F                                                                                                  CML, IML        \[[@B45-molecules-24-00942]\]

  21         2.87                        C~17~H~20~O~9~        368.1104               368.1107                −0.9               367.1031\[M − H\]^−^, 336.0931\[M-H-OCH~3~\]^−^, 203.0655\[M-H-C~9~H~8~O~3~\]^−^, 188.0545\[M-H-CH~3~-C~9~H~8~O~3~\]^−^, 151.0384\[M-H-2H~2~O-C~9~H~8~O~4~\]^−^                                                       Methyl-4-caffeoylquinate                                                                                      CML, IML        \[[@B45-molecules-24-00942]\]

  22         2.96                        C~10~H~20~O~6~        236.1260               236.1261                0.3                259.1153\[M + Na\]^+^, 219.1322\[M + H-H~2~O\]^+^, 176.0465\[M + H-H~2~O-C~3~H~7~\]^+^, 164.0694\[M + H-C~4~H~9~O\]^+^                                                                                                n-Butyl-*β-*[d]{.smallcaps}-fructopyranoside                                                                  CML, IML        \[[@B47-molecules-24-00942]\]

  23         3.00                        C~18~H~26~O~10~       402.1536               402.1526                2.3                425.1428\[M + Na\]^+^, 296.1001\[M + H-C~7~H~7~O\]^+^, 253.1061\[M + H-Xyl\]^+^, 146.0584\[M + H-Xyl-C~7~H~7~O\]^+^, 73.0491\[M + H-Glu-Xyl\]^+^                                                                      Benzyl-*O-β*-[d]{.smallcaps}-xylopyranosyl-(1→6)-*β*-[d]{.smallcaps}-glucopyranoside                          CML, IML        \[[@B18-molecules-24-00942]\]

  24         3.01                        C~19~H~28~O~12~       448.1587               448.1581                1.5                447.1514\[M − H\]^−^,398.1453\[M-H-H~2~O-OCH~3~\]^−^, 378.1102\[M-H-3H~2~O-CH~3~\]^−^, 291.0974\[M-H-C~8~H~12~O~3~\]^−^, 267.1025\[M-H-Glu\]^−^, 193.0447\[M-H-Glu-OCH~3~-COCH~3~\]^−^                                6-*O*-acetylshanzhiside methyl ester                                                                          CML, IML        \[[@B46-molecules-24-00942]\]

  25         3.04                        C~14~H~17~NO~6~       295.1051               295.1056                −1.7               294.0978\[M-H\]^−^, 268.1025\[M-H-CN\]^−^, 162.0436\[M-H-C~8~H~6~NO\]^−^, 130.0390\[M-H-Rha\]^−^, 104.0286\[M-H-Rha-CN\]^−^                                                                                           Niaziridin                                                                                                    CML, IML        \[[@B48-molecules-24-00942]\]

  26         3.13                        C~9~H~8~O~3~          164.0474               164.0473                0.3                165.0544\[M + H\]^+^, 147.0444\[M + H-H~2~O\]^+^, 119.0483\[M + H-HCOOH\]^+^                                                                                                                                          *o*-Coumaric acid                                                                                             CML, IML        \[[@B49-molecules-24-00942]\]

  27         3.23                        C~27~H~30~O~15~       594.1590               594.1585                0.8                593.1517\[M − H\]^−^, 575.1371\[M-H-H~2~O\]^−^, 529.0871\[M-H-H~2~O-Glu\]^−^, 394.1305\[M-H-2H~2~O-C~9~H~6~O~3~\]^−^                                                                                                  Vicenin-2                                                                                                     CML, IML        \[[@B50-molecules-24-00942]\]

  28         3.32                        C~9~H~8~O~3~          164.0471               164.0473                −1.4               165.0544\[M + H\]^+^, 147.0442\[M + H-H~2~O\]^+^, 119.0482\[M + H-HCOOH\]^+^, 107.0495\[M + H-C~2~H~2~O~2~\]^+^                                                                                                       *ρ*-Coumaric acid                                                                                             CML, IML        \[[@B49-molecules-24-00942]\]

  29 \*      3.34                        C~31~H~34~O~14~       630.1943               630.1949                −0.8               675.1939\[M + HCOO\]^−^, 464.0735\[M-H-2CH~3~-C~8~H~7~O~2~\]^−^, 339.0923\[M-H-H~2~O-C~7~H~5~O~2~-C~8~H~7~O~3~\]^−^, 223.0599\[M-H-C~7~H~7~O~2~-Glu benzoate\]^−^, 163.0386\[M-H-C~9~H~9~O~4~-Glu benzoate\]^−^       6′-*O*-Benzoyl-4″-hydroxy-3″-methoxypaeoniflorin                                                              CML \>\> IML\   \[[@B51-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.12\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  30 \*      3.35                        C~16~H~18~O~8~        338.997                338.1002                −1.5               337.0930\[M − H\]^−^, 265.0787\[M-H-4H~2~O\]^−^, 173.0442\[M-H-C~9~H~7~O~3~\]^−^, 162.0386\[M-H-C~7~H~11~O~5~\]^−^, 127.0704\[M-H-HCOOH-C~9~H~7~O~3~\]^−^                                                             3-*p*-Coumaroylquinic acid                                                                                    CML \>\> IML\   \[[@B52-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 9.19\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  31         3.47                        C~27~H~30~O~15~       594.1589               594.1585                0.7                593.1516\[M − H\]^−^, 575.1396\[M-H-H~2~O\]^−^, 411.0869\[M-H-H~2~O-Rha\]^−^, 287.0536\[M-H-H~2~O-Rha-C~6~H~4~O~3~\]^−^, 125.0302\[M-H-Rha-Glu-C~6~H~4~O~3~\]^−^                                                      Kaempferol-3-*O*-rutinoside                                                                                   CML, IML        s

  32         3.54                        C~13~H~16~O~6~        268.0942               268.0947                −1.6               313.0924\[M + HCOO\]^−^, 213.0760\[M-H-3H~2~O\]^−^, 184.0768\[M-H-3H~2~O-CHO\]^−^, 147.0540\[M-H-CH~3~-C~7~H~5~O\]^−^, 103.0284\[M-H-Rha\]^−^                                                                         Benzaldehyde-4-*O-α*-[l]{.smallcaps}-rhamnopyranoside                                                         CML, IML        \[[@B45-molecules-24-00942]\]

  33 \*      3.55                        C~16~H~14~O~7~        318.0746               318.0740                1.9                363.0747\[M + HCOO\]^−^, 208.0473\[M-H-C~6~H~5~O~2~\]^−^, 193.0273\[M-H-CH~3~-C~6~H~5~O~2~\]^−^, 133.0452\[M-H-H~2~O-C~8~H~6~O~4~\]^−^, 121.0284\[M-H-C~9~H~8~O~5~\]^−^                                               Padmatin                                                                                                      CML\            s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.75\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  34         3.89                        C~17~H~20~O~9~        368.1097               368.1107                −2.7               367.1025\[M − H\]^−^, 298.0387\[M-H-3H~2~O-CH~3~\]^−^, 288.1015\[M-H-H~2~O-CH~3~-HCOOH\]^−^, 192.0488\[M-H-C~7~H~11~O~5~\]^−^, 191.0629\[M-H-C~10~H~8~O~3~\]^−^                                                       4-Feruloylquinic acid                                                                                         CML, IML        a

  35         4.02                        C~14~H~17~NO~5~       279.1100               279.1107                −2.1               324.1082\[M + HCOO\]^−^, 188.0725\[M-H-C~3~H~6~O\]^−^, 147.0545\[M-H-CH~3~-C~8~H~6~N\]^−^, 114.0433\[M-H-Rha\]^−^, 88.0545\[M-H-Rha-CN\]^−^                                                                           Niazirin                                                                                                      CML, IML        \[[@B45-molecules-24-00942]\]

  36         4.05                        C~27~H~30~O~17~       626.1487               626.1483                0.7                625.1414\[M − H\]^−^, 445.0853\[M-H-Glu\]^−^, 318.0205\[M-H-Glu-H~2~O-C~6~H~5~O~2~\]^−^, 324.1075\[M-H-C~15~H~9~O~7~\]^−^, 265.0333\[M-H-2Glu\]^−^, 275.0708\[M-H-Glu-H~2~O-C~7~H~4~O~4~\]^−^                         QuerQuercetin-3-gentiobioside                                                                                 CML, IML        a

  37         4.14                        C~15~H~14~O~6~        290.0784               290.0790                −1.8               335.0766\[M + HCOO\]^−^, 162.0243\[M-H-H~2~O-C~6~H~5~O~2~\]^−^, 138.0291\[M-H-H~2~O-C~7~H~6~O~3~\]^−^, 120.0283\[M-H-C~8~H~9~O~4~\]^−^, 79.0342\[M-H-H~2~O-C~10~H~8~O~4~\]^−^                                         Epicatechin                                                                                                   CML, IML        s

  38 \*      4.16                        C~18~H~22~O~8~        366.1324               366.1315                2.5                411.1641\[M + HCOO\]^−^, 335.0765\[M-H-2CH~3~\]^−^, 232.0622\[M-C~9~H~9~O\]^−^, 173.0459\[M-H-CH~3~-C~10~H~9~O~3~\]^−^, 161.0243\[M-CH~3~-Rha ethyl ester\]^−^                                                        3-*O*-acetyl-2-*O*-*p*-methoxycinnamoyl-*α*-[l]{.smallcaps}-rhamnopyranose                                    CML\            \[[@B53-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.69\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  39         4.22                        C~21~H~20~O~11~       448.0999               448.1006                −1.4               447.0926\[M − H\]^−^, 429.0850\[M-H-H~2~O\]^−^, 267.0395\[M-H-Glu\]^−^, 143.0288\[M-H-Glu-C~6~H~4~O~3~\]^−^                                                                                                           Astragalin                                                                                                    CML, IML        \[[@B54-molecules-24-00942]\]

  40         4.47                        C~15~H~14~O~6~        290.0793               297.0790                0.6                335.0775\[M + HCOO\]^−^, 147.0436\[M-H~2~O-C~6~H~4~O~3~\]^−^, 137.0224\[M-H-C~8~H~8~O~3~\]^−^, 133.0295\[M-H-H~2~O-C~7~H~6~O~3~\]^−^, 90.0342\[M-H-H~2~O-C~9~H~9~O~4~\]^−^                                            Catechin                                                                                                      CML, IML        s

  41         4.49                        C~21~H~20~O~12~       464.0955               464.0949                −1.2               465.1022\[M + H\]^+^, 285.0485\[M + H-Glu\]^+^, 231.0678\[M + H-Glu-3H~2~O\]^+^, 149.0150\[M + H-Glu-C~7~H~4~O~3~\]^+^, 152.0154\[M + H-Glu-C~8~H~5~O~2~\]^+^                                                         Hyperoside                                                                                                    CML, IML        s

  42         4.50                        C~27~H~30~O~17~       626.1475               626.1483                −1.3               625.1402\[M − H\]^−^, 516.1277\[M-H-C~6~H~5~O~2~\]^−^, 396.0689\[M-H-Glu-H~2~O-CH~2~OH\]^−^, 265.0264\[M-H-2Glu\]^−^, 132.9991\[M-H-2Glu-C~8~H~5~O~2~\]^−^                                                            Quercetin-3-sophoroside                                                                                       CML, IML        a

  43         4.52                        C~26~H~28~O~16~       596.1400               596.1377                3.8                595.1327\[M − H\]^−^, 265.0264\[M-H-Glu-Xyl\]^−^, 138.0156\[M-H-Glu-Xyl-H~2~O-C~6~H~5~O~2~\]^−^, 115.9991\[M-H-Glu-Xyl-C~8~H~6~O~3~\]^−^, 144.0485\[M-H-Xyl-C~15~H~9~O~7~\]^−^                                        Quercetin-3-*O-β*-[d]{.smallcaps}-xylopyranosyl-(1→2)-*β*-[d]{.smallcaps}-glucopyranoside                     CML, IML        a

  44         4.67                        C~21~H~20~O~12~       464.0939               464.0955                −3.4               463.0866\[M − H\]^−^, 318.0758\[M-H-2H~2~O-C~6~H~5~O~2~\]^−^, 178.0513\[M-H-C~15~H~9~O~6~\]^−^, 159.0379\[M-H-Glu-C~6~H~4~O~3~\]^−^                                                                                   Isoquercetin                                                                                                  CML, IML        \[[@B54-molecules-24-00942]\]

  45         4.68                        C~27~H~30~O~14~       578.1635               578.1636                −0.2               579.1707\[M + H\]^+^, 543.1466\[M + H-2H~2~O\]^+^, 415.1130\[M + H-Rha\]^+^, 322.0748\[M + H-Rha-C~6~H~5~O\]^+^, 235.0580\[M + H-Glu-Rha\]^+^                                                                         Apigenin-7-*O*-rutinoside                                                                                     CML, IML        \[[@B39-molecules-24-00942]\]

  46         4.71                        C~27~H~30~O~15~       594.1596               594.1585                2.0                593.1524\[M − H\]^−^, 413.0899\[M-H-Glu\]^−^, 338.0756\[M-H-Glu-H~2~O-C~2~HO~2~\]^−^, 247.0305\[M-H-Rha-Glu\]^−^, 160.0677\[M-H-Rha-C~15~H~9~O~5~\]^−^                                                                Kaempferol-3-*O-α*-[l]{.smallcaps}-rhamnoside-(1→4)-*β-*[d]{.smallcaps}-glucoside                             CML, IML        a

  47         4.82                        C~26~H~34~O~11~       522.2118               522.2101                3.0                567.2100\[M + HCOO\]^−^, 461.2005\[M-H-C~2~H~4~O\]^−^, 341.1509\[M-H-Glu\]^−^, 401.1193\[M-H-C~9~H~12~\]^−^, 200.0871\[M-H-Glu-H~2~O-C~7~H~7~O~2~\]^−^, 134.0427\[M-H-Glu-C~12~H~15~O~3~\]^−^                         Ligan glycoside A                                                                                             CML, IML        b

  48         4.85                        C~26~H~28~O~14~       564.1475               564.1479                −0.7               565.1548\[M + H\]^+^, 418.1217\[M + H-C~9~H~6~O~2~\]^+^, 298.0909\[M + H-Api-C~8~H~6~O\]^+^, 180.0776\[M + H-Api-C~15~H~9~O~4~\]^+^, 147.0593\[M + H-Glu-Api-C~6~H~3~O~2~\]^+^                                        Apiin                                                                                                         CML, IML        \[[@B55-molecules-24-00942]\]

  49         4.95                        C~15~H~10~O~7~        302.0429               302.0427                0.7                303.0501\[M + H\]^+^, 153.0162\[M + H-C~8~H~6~O~3~\]^+^, 151.0210\[M + H-C~7~H~4~O~4~\]^+^, 122.0388\[M + H-C~9~H~6~O~4~\]^+^                                                                                         Quercetin                                                                                                     CML, IML        s

  50 ^\#^    4.97                        C~27~H~30~O~16~       610.1537               610.1534                0.6                611.1652\[M + H\]^+^, 447.1016\[M + H-Rha\]^+^, 267.0509\[M + H-Glu-Rha\]^+^, 158.0289\[M + H-Glu-Rha-C~6~H~5~O~2~\]^+^, 131.0222\[M + H-Glu-Rha-C~7~H~4~O~3~\]^+^                                                    Rutin                                                                                                         CML \<\< IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 8.51\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  51 ^\#^    5.01                        C~27~H~30~O~16~       610.1532               610.1534                −0.3               609.1472\[M − H\]^−^, 427.0974\[M-H-Rha-H~2~O\]^−^, 336.0683\[M-H-Rha-C~6~H~5~O~2~\]^−^, 265.0326\[M-H-Glu-Rha\]^−^, 132.0015\[M-H-Glu-Rha-C~8~H~5~O~2~\]^−^                                                          Quercetin-3-rutinoside                                                                                        CML \<\< IML\   \[[@B56-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 13.28\     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  52         5.02                        C~21~H~20~O~10~       432.1048               432.1056                −2.0               431.0975\[M − H\]^−^, 395.0746\[M-H-2H~2~O\]^−^, 338.0683\[M-H-C~6~H~5~O\]^−^, 251.0447\[M-H-Glu\]^−^, 100.0326\[M-H-Glu-C~7~H~3~O~4~\]^−^                                                                            Apigenin-8-C-glucoside                                                                                        CML, IML        \[[@B39-molecules-24-00942]\]

  53         5.04                        C~21~H~20~O~10~       432.1069               432.1056                2.7                477.1051\[M + HCOO\]^−^, 267.0464\[M-H-Rha\]^−^, 163.0701\[M-H-C~15~H~8~O~5~\]^−^, 115.0438\[M-H-Rha-C~7~H~4~O~4~\]^−^                                                                                                Kaempherol-3-*O-α*-rhamnoside                                                                                 CML, IML        \[[@B41-molecules-24-00942]\]

  54         5.08                        C~15~H~19~NO~5~       293.1265               293.1263                0.5                294.1337\[M + H\]^+^, 131.0526\[M + H-OCH~3~-C~8~H~6~NO\]^+^, 99.0646\[M + H-Rha-OCH~3~\]^+^                                                                                                                          4-(4 ′-*O*-methyl-*α-*[l]{.smallcaps}-rhamnosyloxy)benzyl nitrile                                             CML, IML        \[[@B18-molecules-24-00942]\]

  55 \*      5.22                        C~21~H~20~O~12~       464.0938               464.0955                −3.5               463.0880\[M − H\]^−^, 283.0502\[M-H-Glu\]^−^, 174.0278\[M-H-Glu-C~6~H~5~O~2~\]^−^, 150.0174\[M-H-Glu-C~8~H~5~O~2~\]^−^                                                                                                Quercetin 3-*O-β*-[d]{.smallcaps}-glucopyranoside                                                             CML \>\> IML\   \[[@B56-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 7.30\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  56         5.48                        C~15~H~14~O~5~        274.0837               274.0841                −1.2               319.0819\[M + HCOO\]^−^, 144.0281\[M-H-2H~2~O-C~6~H~5~O\]^−^, 137.0222\[M-H-C~8~H~8~O~2~\]^−^, 117.0329\[M-H-H~2~O-C~7~H~6~O~3~\]^−^, 92.0344\[M-H-C~9~H~9~O~4~\]^−^                                                  (−)-Epiafzelechin                                                                                             CML, IML        s

  57         5.55                        C~27~H~30~O~17~       626.1490               626.1483                1.1                625.1417\[M − H\]^−^, 571.1354\[M-H-3H~2~O\]^−^, 391.0807\[M-H-Glu-3H~2~O\]^−^, 303.0966\[M-H-Glu-H~2~O-C~6~H~3~O~2~\]^−^, 265.0399\[M-H-2Glu\]^−^                                                                    Quercetin-3,7-*O-β*-[d]{.smallcaps}-diglucopyranoside                                                         CML, IML        a

  58         5.65                        C~24~H~22~O~15~       550.0957               550.0959                −0.2               549.0885\[M − H\]^−^, 445.0780\[M-H-malonyl\]^−^, 300.0267\[M-H-malonyl-Glu\]^−^, 160.0133\[M-H-malonyl-Glu-C~6~H~4~O~3~\]^−^                                                                                         Quercetin-3-*O*-(6″-malonyl) glucoside                                                                        CML, IML        \[[@B49-molecules-24-00942]\]

  59 ^\#^    5.67                        C~27~H~30~O~15~       594.1579               594.1585                −1.0               595.1678\[M + H\]^+^, 448.1063\[M + H-3H~2~O-C~6~H~5~O\]^+^, 385.1335\[M + H-Glu-C~2~HO\]^+^, 304.0494\[M + H-H~2~O-Glu-C~6~H~5~O\]^+^, 142.0169\[M + H-2Glu-C~6~H~5~O\]^+^                                           Isovitexin-3″-*O*-glucopyranoside                                                                             CML \<\< IML\   \[[@B57-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 5.63\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  60 ^\#^    5.69                        C~30~H~26~O~13~       594.1355               594.1373                −3.1               593.1507\[M − H\]^−^, 484.1116\[M-H-C~6~H~5~O~2~\]^−^, 439.0848\[M-H-C~7~H~6~O~4~\]^−^, 286.0394\[M-H-H~2~O-C~15~H~13~O~6~\]^−^, 153.9989\[M-H-C~23~H~20~O~9~\]^−^                                                    Procyanidins                                                                                                  CML \<\< IML\   \[[@B58-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 7.04\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  61         5.72                        C~27~H~28~O~16~       608.1378               608.1377                0.0                607.1305\[M − H\]^−^, 543.1275\[M-H-H~2~O-HCOOH\]^−^, 504.0985\[M-H-C~4~H~7~O~3~\]^−^, 440.0889\[M-H-H~2~O-C~5~H~9~O~3~\]^−^, 462.0868\[M-H-C~6~H~9~O~4~\]^−^, 282.0267\[M-H-Glu-C~6~H~9~O~4~\]^−^                    Quercetin-3-*O*-hydroxy methylglutaroyl galactoside                                                           CML, IML        \[[@B59-molecules-24-00942]\]

  62 ^\#^    5.84                        C~28~H~32~O~16~       624.1703               624.1690                2.1                623.1611\[M − H\]^−^, 590.1383\[M-H-H~2~O-CH~3~\]^−^, 466.1438\[M-H-2H~2~O-C~7~H~7~O~2~\]^−^, 337.0986\[M-H-Rha-C~6~H~4~O~3~\]^−^, 281.0460\[M-H-Glu-Rha\]^−^                                                         Isorhamnetin-3-*O*-rutinoside                                                                                 CML \<\< IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.90\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  63\*       5.92                        C~21~H~20~O~11~       448.1003               448.1006                −0.7               447.0929\[M − H\]^−^, 267.0463\[M-H-Glu\]^−^, 227.0343\[M-H-Glu-C~2~O\]^−^, 134.0018\[M-H-Glu-C~8~H~5~O~2~\]^−^                                                                                                       Kaempferol-3-*O*-glucoside                                                                                    CML \>\> IML\   \[[@B49-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 10.89\     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  64         6.07                        C~16~H~12~O~7~        316.0581               316.0583                −0.6               317.0654\[M + H\]^+^, 302.0412\[M + H-CH~3~\]^+^, 299.0533\[M + H-H~2~O\]^+^, 152.0169\[M + H-C~9~H~8~O~3~\]^+^, 125.0388\[M + H-C~10~H~8~O~4~\]^+^                                                                   Isorhamnetin                                                                                                  CML, IML        s

  65         6.16                        C~23~H~22~O~13~       506.1068               506.1060                1.4                505.0995\[M − H\]^−^, 490.0815\[M-H-CH~3~\]^−^, 428.0988\[M-H-H~2~O-OCOCH~3~\]^−^, 317.0980\[M-H-2H~2~O-C~7~H~4~O~4~\]^−^, 283.0198\[M-H-Glu ethyl ester\]^−^                                                         Quercetin-3-*O*-(6″-*O*-acetyl)-*β*-[d]{.smallcaps}-glucopyranoside                                           CML, IML        \[[@B49-molecules-24-00942]\]

  66         6.24                        C~9~H~16~O~4~         188.1045               188.1049                2.1                187.0965\[M − H\]^−^, 141.1105\[M-H-HCOOH\]^−^, 123.0957\[M-H-H~2~O-HCOOH\]^−^, 112.0644\[M-H-H~2~O-C~3~H~5~O\]^−^                                                                                                    Azelaic acid                                                                                                  CML, IML        s

  67         6.28                        C~22~H~22~O~9~        430.1242               430.1264                −4.7               475.1224\[M + HCOO\]^−^, 288.0536\[M-H-H~2~O-C~7~H~7~O~2~\]^−^, 244.0915\[M-H-2H~2~O-C~9~H~8~O~2~\]^−^, 143.0398\[M-H-CH~3~-Rha-C~6~H~3~O~2~\]^−^, 130.0289\[M-H-Rha-C~7~H~3~O~3~\]^−^                                Chryseriol-7-*O*-rhamnoside                                                                                   CML, IML        \[[@B39-molecules-24-00942]\]

  68         6.43                        C~36~H~36~O~18~       756.1900               756.1902                −0.3               755.1827\[M − H\]^−^, 737.1844\[M-H-H~2~O\]^−^, 575.1386\[M-H-Glu\]^−^, 427.0933\[M-H-Glu-C~9~H~7~O~2~\]^−^, 405.0904\[M-H-Glu-H~2~O-C~7~H~4~O~4~\]^−^, 247.0320\[M-H-2Glu-C~9~H~7~O~2~\]^−^                          Allivictoside A                                                                                               CML, IML        b

  69 \*      6.44                        C~34~H~24~O~10~       592.1387               592.1370                3.0                593.1639\[M + H\]^+^, 483.1521\[M + H-H~2~O-C~6~H~4~O\]^+^, 266.0696\[M + H-C~8~H~5~O~2~-C~10~H~10~O~2~\]^+^, 241.0502\[M + H-C~20~H~16~O~6~\]^+^, 134.0267\[M + H-C~26~H~19~O~8~\]^+^                                Mulberrofuran Q                                                                                               CML \>\> IML\   \[[@B59-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 5.76\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  70         6.46                        C~24~H~22~O~14~       534.1014               534.1010                0.8                533.0941\[M − H\]^−^, 447.0920\[M-H-malonyl\]^−^, 323.0962\[M-H-malonyl-C~6~H~4~O~3~\]^−^, 284.0320\[M-H-malonyl-Glu\]^−^                                                                                             Kaempferol-3-*O*-(6″-malonyl) glucoside                                                                       CML, IML        \[[@B49-molecules-24-00942]\]

  71         6.74                        C~22~H~20~O~12~       476.0964               476.0955                1.8                475.0891\[M − H\]^−^, 444.0726\[M-H-OCH~3~\]^−^, 351.0892\[M-H-C~6~H~4~O~3~\]^−^, 283.0394\[M-H-methyl glucuronate\]^−^, 172.0452\[M-H-H~2~O-C~15~H~9~O~6~\]^−^                                                       Kaempferol-3-*O-β*-[d]{.smallcaps}-glucuronide-6″-methyl ester                                                CML, IML        \[[@B60-molecules-24-00942]\]

  72         6.98                        C~21~H~20~O~10~       432.1052               432.1056                −1.1               431.0979\[M − H\]^−^, 267.0327\[M-H-Rha\]^−^, 249.0447\[M-H-Rha-H~2~O\]^−^, 157.9997\[M-H-Rha-C~6~H~6~O~2~\]^−^                                                                                                       Kaempferol-7-*O-α*-[l]{.smallcaps}-rhamnoside                                                                 CML, IML        \[[@B61-molecules-24-00942]\]

  73         6.99                        C~15~H~10~O~6~        286.0484               286.0477                2.4                287.0557\[M + H\]^+^, 153.0167\[M + H-C~8~H~6~O~2~\]^+^, 135.0583\[M + H-C~7~H~4~O~4~\]^+^, 124.0385\[M + H-C~9~H~6~O~3~\]^+^                                                                                         Orobol                                                                                                        CML, IML        \[[@B62-molecules-24-00942]\]

  74 \*      7.01                        C~23~H~22~O~12~       490.1108               490.1111                −0.6               489.1039\[M − H\]^−^, 446.1001\[M-H-COCH~3~\]^−^, 267.0323\[M-H-Glu ethyl ester\]^−^, 143.0443\[M-H-Glu ethyl ester-C~6~H~4~O~3~\]^−^                                                                                 3-*O*-(6″-*O*-acetyl)-*β[-]{.smallcaps}*[d]{.smallcaps}-glucopyranside                                        CML \>\> IML\   \[[@B63-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 6.15\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  75         7.80                        C~16~H~19~NO~6~       321.1213               321.1212                0.2                366.1195\[M + HCOO\]^−^, 249.0617\[M-H-OCH ~3~-C~2~H~2~N\]^−^, 189.0517\[M-H-CH~3~-C~8~H~6~N\]^−^, 97.0370\[M-H-Rha-C~2~H~3~O~2~\]^−^                                                                                 Niazirinin                                                                                                    CML, IML        \[[@B45-molecules-24-00942]\]

  76         7.86                        C~15~H~10~O~6~        286.0477               286.0473                −1.7               285.0400\[M − H\]^−^, 121.0377\[M-H-C~6~H~4~O~3~\]^−^, 183.0010\[M-H-C~8~H~6~\]^−^, 133.0415\[M-H-C~7~H~4~O~4~\]^−^, 108.0280\[M-H-C~9~H~5~O~4~\]^−^                                                                  Luteolin                                                                                                      CML, IML        s

  77         7.89                        C~15~H~10~O~7~        302.0408               302.0427                −1.8               301.0336\[M − H\]^−^, 244.0329\[M-H-C~2~HO~2~\]^−^, 190.0130\[M-H-H~2~O-C~6~H~5~O\]^−^, 133.0269\[M-H-C~7~H~4~O~5~\]^−^, 92.0343\[M-H-C~9~H~5~O~6~\]^−^                                                               6-Hydroxykaempferol                                                                                           CML, IML        \[[@B64-molecules-24-00942]\]

  78 ^\#^    7.89                        C~28~H~32~O~17~       640.1653               640.1639                2.1                663.3153\[M + Na\]^+^, 443.0906\[M + H-Glu-H~2~O\]^+^, 281.0480\[M + H-2Glu\]^+^, 266.0487\[M + H-2Glu-CH~3~\]^+^, 158.0315\[M + H-2Glu-C~7~H~7~O~2~\]^+^                                                             Isorhamnetin 3-*O-β*-gentiobioside                                                                            CML \<\< IML\   a
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 4.79\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  79 \*      8.01                        C~15~H~10~O~6~        286.0479               286.0477                0.6                287.0567\[M + H\]^+^, 163.0580\[M + H-C~6~H~4~O~3~\]^+^, 147.0435\[M + H-C~6~H~4~O~4~\]^+^, 124.0384\[M + H-C~9~H~6~O~3~\]^+^                                                                                         Scutellarein                                                                                                  CML \>\> IML\   \[[@B65-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.69\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  80 \*      8.02                        C~25~H~24~O~12~       516.1266               516.1268                −0.3               515.1203\[M − H\]^−^, 451.1465\[M-H-H~2~O-HCOOH\]^−^, 326.0487\[M-H-3H~2~O-C~8~H~7~O~2~\]^−^, 219.0638\[M-H-2C~9~H~7~O~2~\]^−^, 143.0279\[M-H-H~2~O-C~16~H~18~O~9~\]^−^                                               1,3-Dicaffeoylquinic acid                                                                                     CML \>\> IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 4.25\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  81 ^\#^    8.26                        C~20~H~26~O~9~        410.1573               410.1577                −1.0               409.1504\[M − H\]^−^, 336.0817\[M-H-C~4~H~9~O\]^−^, 251.1394\[M-H-2H~2~O-C~7~H~6~O~2~\]^−^, 202.0639\[M-H-C~3~H~7~-C~9~H~7~O~3~\]^−^, 134.0437\[M-H-C~12~H~19~O~7~\]^−^                                               5-*O*-Caffeoylquinic acid butyl ester                                                                         CML \<\< IML\   a
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 4.72\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  82 ^\#^    8.52                        C~38~H~48~O~19~       808.2757               808.2790                −3.9               853.2706\[M + HCOO\]^−^, 700.2173\[M-H-C~7~H~7~O\]^−^, 572.1546\[M-H-C~4~H~7~-Glu\]^−^, 438.1262\[M-H-C~4~H~7~-Rha-Ara\]^−^, 274.1182\[M-H-Glu-Ara-C~12~H~11~O~3~\]^−^                                                7-(*α*-L-Galactopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4-oxo-4*H*-chromen      IML\            b
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.08\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  83         9.08                        C~30~H~34~O~15~       634.1872               634.1898                −3.7               679.1854\[M + HCOO\]^−^, 600.1579\[M-H-H~2~O-CH~3~\]^−^, 454.10677\[M-H-Rha-CH~3~\]^−^, 411.0997\[M-H-CH~3~-Rha ethyl ester\]^−^, 334.0931\[M-H-Rha-C~7~H~3~O~3~\]^−^, 296.0665\[M-H-C~9~H~7~O-Rha ethyl ester\]^−^   Kaempferol-3-*O-α*-[l]{.smallcaps}-(4-*O*-acetyl)-rhamnosyl-7-*O-α*-[l]{.smallcaps}-rhamnoside                CML, IML        \[[@B41-molecules-24-00942]\]

  84 \*      9.23                        C~15~H~10~O~6~        286.0473               286.0477                −1.7               285.0435\[M − H\]^−^, 228.0285\[M-H-C~2~HO~2~\]^−^, 161.0377\[M-H-C~6~H~4~O~3~\]^−^, 151.0010\[M-H-C~8~H~6~O~2~\]^−^                                                                                                  Kaempferol                                                                                                    CML \>\> IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 4.99\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  85         9.31                        C~14~H~17~NO~5~S      311.0821               311.0827                −1.9               356.0803\[M + HCOO\]^−^, 252.0915\[M-H-NCS\]^−^, 162.0681\[M-H-C~8~H~6~NS\]^−^, 88.0495\[M-H-Rha-NCS\]^−^                                                                                                             4-\[(*α*-[l]{.smallcaps}-rhamnosyloxy) benzyl\] Isothiocyanate                                                CML, IML        \[[@B66-molecules-24-00942]\]

  86         9.47                        C~16~H~12~O~7~        316.0575               316.0583                −2.4               315.0503\[M − H\]^−^, 300.0268\[M-H-CH~3~\]^−^, 282.0400\[M-H-H~2~O-CH~3~\]^−^, 191.0163\[M-H-CH~3~-C~6~H~5~O~2~\]^−^, 165.0069\[M-H-C~8~H~6~O~3~\]^−^                                                                Rhamnetin                                                                                                     CML, IML        \[[@B18-molecules-24-00942]\]

  87         9.54                        C~12~H~16~O~4~        224.1038               224.1049                −4.8               223.0965\[M − H\]^−^, 205.1027\[M-H-H~2~O\]^−^, 135.0421\[M-H-C~4~H~8~O~2~\]^−^, 123.0964\[M-H-C~4~H~4~O~3~\]^−^, 87.0295\[M-H-C~8~H~8~O~2~\]^−^                                                                      3-Butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone                                          CML, IML        \[[@B67-molecules-24-00942]\]

  88         9.69                        C~30~H~36~O~4~        460.2612               460.2614                −0.4               505.2629\[M + HCOO\]^−^, 444.2249\[M-H-CH~3~\]^−^, 372.1847\[M-H-H~2~O-C~5~H~9~\]^−^, 240.1718\[M-H-CH~3~-C~12~H~12~O~3~\]^−^, 139.0822\[M-H-H~2~O-C~4~H~7~O-C~14~H~15~O~3~\]^−^                                      Sophoranone                                                                                                   CML, IML        a

  89         9.94                        C~15~H~10~O~6~        286.0480               286.0477                1.1                287.0553\[M + H\]^+^, 153.0163\[M + H-C~8~H~6~O~2~\]^+^, 135.0449\[M + H-C~7~H~4~O~4~\]^+^, 124.0382\[M + H-C~9~H~6~O~3~\]^+^, 110.0281\[M + H-C~9~H~5~O~4~\]^+^                                                      5,7,2′,5′-Tetrahydroxyflavone                                                                                 CML, IML        b

  90         9.98                        C~27~H~28~O~12~       544.1583               544.1581                0.4                589.1565\[M + HCOO\]^−^, 375.1260\[M-H-C~6~H~5~O~2~-C~2~H~3~O~2~\]^−^, 328.0465\[M-H-H~2~O-2OCH~3~-C~8~H~7~O~2~\]^−^, 244.0508\[M-H-C~9~H~7~O~3~-C~8~H~7~O~2~\]^−^, 153.0016\[M-H-2OCH~3~-2C~9~H~7~O~3~\]^−^          1-*O*-methyl-3,5-*O*-dicaffeoylquinic acid methyl ester                                                       CML, IML        a

  91         10.10                       C~29~H~32~O~15~       620.1741               620.1758                2.6                621.1830\[M + H\]^+^, 507.1514\[M + H-C~9~H~6~\]^+^, 310.0986\[M + H-Rha-C~9~H~6~O~2~\]^+^, 147.0658\[M + H-Glu ethyl ester-C~15~H~9~O~4~\]^+^                                                                        Apigenin-7-O-*α*-[l]{.smallcaps}-rhamnopyranosyl(1 → 4)-6″-O-acetyl-*β*-[d]{.smallcaps}-glucopyranoside       CML, IML        \[[@B68-molecules-24-00942]\]

  92         10.30                       C~18~H~34~O~5~        330.2405               330.2406                −0.4               329.2332\[M − H\]^−^, 293.2084\[M-H-2H~2~O\]^−^, 226.1434\[M-H-H~2~O-C~6~H~13~\]^−^, 212.1325\[M-H-HCOOH-C~5~H~11~\]^−^, 168.1004\[M-H-H~2~O-C~9~H~19~O\]^−^, 137.1117\[M-H-H~2~O-C~3~H~7~-C~6~H~11~O~3~\]^−^         Sanleng acid                                                                                                  CML, IML        \[[@B26-molecules-24-00942]\]

  93 \*      10.39                       C~10~H~12~O~2~        164.0837               164.0831                −2.8               209.1118\[M + HCOO\]^−^, 122.0453\[M-H-C~3~H~5~\]^−^, 105.0495\[M-H-OCH~3~-C~2~H~3~\]^−^                                                                                                                              Eugenol                                                                                                       CML \>\> IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.57\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  94         10.52                       C~15~H~10~O~6~        286.0477               286.0478                0.1                287.0550\[M + H\]^+^, 256.0427\[M + H-OCH~3~\]^+^, 167.0167\[M + H-C~7~H~4~O~2~\]^+^, 137.0227\[M + H-C~8~H~6~O~3~\]^+^, 121.0434\[M + H-C~8~H~6~O~4~\]^+^                                                            1,7-Dihydroxy-2,3-methylenedioxyxanthone                                                                      CML, IML        b

  95         10.67                       C~15~H~30~O~2~        242.2241               242.2246                −1.6               287.2223\[M + HCOO\]^−^, 170.1211\[M-H-C~5~H~11~\]^−^, 153.1120\[M-H-OCH~3~-C~4~H~9~\]^−^, 97.0818\[M-H-OCH~3~-C~8~H~17~\]^−^, 69.0512\[M-H-OCH~3~-C~10~H~21~\]^−^                                                    Methyl myristate                                                                                              CML, IML        s

  96         10.73                       C~15~H~10~O~6~        286.0480               286.0477                0.8                287.0552\[M + H\]^+^, 153.0171\[M + H-C~8~H~6~O~2~\]^+^, 124.0390\[M + H-C~9~H~6~O~3~\]^+^, 110.0285\[M + H-C~9~H~5~O~4~\]^+^                                                                                         2′-Hydroxygenistein                                                                                           CML, IML        s

  97 ^\#^    11.22                       C~18~H~34~O~5~        330.2393               330.2406                −4.0               329.2320\[M − H\]^−^, 213.1323\[M-H-C~2~H~5~-C~4~H~7~O~2~\]^−^, 208.1038\[M-H-2H~2~O-C~6~H~13~\]^−^, 183.1403\[M-H-H~2~O-C~7~H~13~O~2~\]^−^, 170.1223\[M-H-C~8~H~15~O~3~\]^−^                                         Tianshic acid                                                                                                 CML \<\< IML\   \[[@B69-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 1.52\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  98         11.35                       C~16~H~19~NO~6~S      353.0930               353.0933                −0.8               398.0912\[M + HCOO\]^−^, 262.1963\[M-H-H~2~O-C~2~H~2~NS\]^−^, 236.0926\[M-H-CH~3~-COCH~3~-C~2~H~2~S\]^−^, 150.0741\[M-H-C~2~H~2~NS-C~6~H~10~O~3~\]^−^                                                                 4-\[(4′-*O*-acetyl-*α*-[l]{.smallcaps}-rhamnosyloxy)benzyl\]isothiocyanate                                    CML, IML        \[[@B66-molecules-24-00942]\]

  99         11.86                       C~12~H~14~O~2~        190.0988               190.0994                −2.4               235.0970\[M + HCOO\]^−^, 146.0415\[M-H-C3H7\]^−^, 132.0273\[M-H-C4H9\]^−^, 113.0743\[M-H-C6H4\]^−^                                                                                                                    3-n-Butylphthalide                                                                                            CML, IML        a

  100 ^\#^   11.95                       C~32~H~50~O~14~       658.3196               658.3201                −0.8               681.2695\[M + Na\]^+^, 617.2802\[M + H-C~3~H~6~\]^+^, 448.2238\[M + H-Glu-CH~2~OH\]^+^, 397.2184\[M + H-Glu-C~6~H~10~\]^+^, 203.0848\[M + H-2Glu-C~7~H~12~\]^+^                                                       Ajugaside A                                                                                                   CML \<\< IML\   \[[@B70-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.40\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  101        12.01                       C~30~H~40~O~12~       592.2544               592.2520                4.1                591.2471\[M − H\]^−^, 561.2176\[M-H-2CH~3~\]^−^, 365.1552\[M-H-CH~3~-OCH~3~-Glu\]^−^, 315.1166\[M-H-C~16~H~20~O~4~\]^−^, 211.1134\[M-H-Glu-C~11~H~12~O~3~\]^−^                                                        Syringaresinolmono-*β*-[d]{.smallcaps}-glucoside                                                              CML, IML        \[[@B71-molecules-24-00942]\]

  102        12.21                       C~12~H~14~O~4~        222.0883               222.0892                −3.9               221.0811\[M − H\]^−^, 160.0546\[M-H-OC~2~H~5~\]^−^, 119.0282\[M-H-C~3~H~5~O~2~-C~2~H~5~\]^−^,                                                                                                                         Diethyl phthalate                                                                                             CML, IML        \[[@B67-molecules-24-00942]\]

  103        12.22                       C~16~H~19~NO~6~S      353.0930               353.0933                −0.8               398.0912\[M + HCOO\]^−^, 265.0805\[M-H-COCH~3~-CS\]^−^, 161.0338\[M-H-COCH~3~-C~8~H~6~NS\]^−^, 101.0359\[M-H-Rha-COCH~3~-CS\]^−^                                                                                      4-\[(2′-*O*-acetyl-*α*-[l]{.smallcaps}-rhamnosyloxy) benzyl\] Isothiocyanate                                  CML, IML        \[[@B49-molecules-24-00942]\]

  104 ^\#^   12.98                       C~20~H~23~N~7~O~7~    473.1668               473.1659                1.9                472.1665\[M − H\]^−^, 423.1223\[M-H-H~2~O-NH~2~-NH\]^−^, 383.1668\[M-H-H~2~O-CHO-CH~2~N~2~\]^−^, 351.0896\[M-H-H~2~O-HCOOH-CH~3~N~3~\]^−^, 164.0386\[M-H-CHO-CH~3~N-C~12~H~12~NO~5~\]^−^                              Folinic acid                                                                                                  CML \<\< IML\   a
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.43\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  105        13.10                       C~21~H~38~O~4~        354.2757               354.2770                −3.3               399.2739\[M + HCOO\]^−^, 324.2187\[M-H-C~2~H~5~\]^−^, 238.1479\[M-H-H~2~O-C~7~H~13~\]^−^, 202.1101\[M-H-C~11~H~19~\]^−^, 151.1152\[M-H-C~8~H~15~-C~3~H~7~O~3~\]                                                       2-Monolinolein                                                                                                CML, IML        \[[@B26-molecules-24-00942]\]

  106        13.29                       C~35~H~52~O~14~       696.3375               696.3357                2.4                741.3357\[M + HCOO\]^−^, 571.2800\[M-H-C~7~H~8~O~2~\]^−^, 433.2317\[M-H-Glu-2H~2~O-HCOOH\]^−^, 366.2232\[M-H-Glu-Ribose\]^−^, 303.2063\[M-H-Glu-H~2~O-C~11~H~14~O~3~\]^−^                                             Erysimosole                                                                                                   CML, IML        b

  107        13.40                       C~21~H~31~NO~10~S     489.1682               489.1669                2.8                488.1610\[M − H\]^−^, 473.1683\[M-H-CH~3~\]^−^, 308.1280\[M-H-Glu\]^−^, 293.0912\[M-H-CH~3~-Glu\]^−^, 218.0984\[M-H-Glu-H~2~O-C~2~H~2~NS\]^−^                                                                         4-\[(*β*-[d]{.smallcaps}-glucopyranosyl-1-4-*α-*[l]{.smallcaps}-rhamnopyranosyloxy) benzyl\] Isothiocyanate   CML, IML        a

  108        13.52                       C~13~H~16~O~3~        220.1095               220.1099                −1.9               219.1023\[M − H\]^−^, 164.0378\[M-H-C~4~H~7~\]^−^, 145.0326\[M-H-OCH~3~-C~3~H~7~\]^−^                                                                                                                                 4-(1-Oxopentyl)-methyl ester,Benzoic acid                                                                     CML, IML        a

  109        14.68                       C~18~H~34~O~4~        314.2443               314.2457                −4.6               313.2370\[M − H\]^−^, 199.1107\[M-H-2C~4~H~9~\]^−^, 184.1370\[M-H-C~7~H~13~O~2~\]^−^, 155.1048\[M-H-C~9~H~17~O~2~\]^−^, 125.1126\[M-H-C~4~H~9~O-C~6~H~11~O~2~\]^−^                                                    Dibutyl sebacate                                                                                              CML, IML        s

  110        15.87                       C~18~H~28~O~2~        276.2099               276.2089                3.3                277.2171\[M + H\]^+^, 150.1315\[M + H-C~7~H~11~O~2~\]^+^, 136.1167\[M + H-C~8~H~13~O~2~\]^+^, 107.0704\[M + H-C~5~H~9~-C~5~H~9~O~2~\]^+^, 95.0708\[M + H-C~4~H~7~-C~7~H~11~O~2~\]^+^                                  Parinaric acid                                                                                                CML, IML        s

  111        15.93                       C~15~H~22~O~4~        266.1506               266.1518                −3.8               265.1488\[M − H\]^−^, 247.1494\[M-H-H~2~O\]^−^, 211.1328\[M-H-C~3~H~2~O\]^−^, 180.1365\[M-H-CH~3~-C~3~H~2~O~2~\]^−^, 169.1007\[M-H-C~3~H~6~-C~3~H~2~O\]^−^, 133.1009\[M-H-H~2~O-C~5~H~6~O~3~\]^−^                     4*α*,6*α*-Dihydroxyeud-esman-8*β*,12-olide                                                                    CML, IML        a

  112        16.00                       C17H34O2              270.2556               270.2559                −0.9               315.2538\[M + HCOO\]^−^, 254.2163\[M-H-CH~3~\]^−^, 139.1285\[M-H-OCH~3-~C~7~H~15~\]^−^, 125.1118\[M-H-OCH~3-~C~8~H~17~\]^−^                                                                                           Methyl palmitate                                                                                              CML, IML        s

  113        16.49                       C~18~H~30~O~4~        310.2142               310.2144                −0.6               309.2069\[M − H\]^−^, 291.1964\[M-H-H~2~O\]^−^, 245.2069\[M-H-H~2~O-HCOOH\]^−^, 208.1397\[M-H-C~5~H~9~O~2~\]^−^, 198.1177\[M-H-C~7~H~11~O\]^−^, 135.0958\[M-H-C~9~H~17~O~3~\]^−^                                      9,16-Dihydroxy-10,12,14-octadecatrienoic acid                                                                 CML, IML        b

  114        17.88                       C~16~H~30~O~2~        254.2259               254.2246                4.8                277.2151\[M + Na\]^+^, 237.2359\[M + H-H~2~O\]^+^, 97.1016\[M + H-C~2~H~5~-C~7~H~13~O~2~\]^+^, 88.0605\[M + H-C~12~H~23~\]^+^, 69.0716\[M + H-C~4~H~9~-C~7~H~13~O~2~\]^+^                                             Palmitoleic acid                                                                                              CML, IML        \[[@B32-molecules-24-00942]\]

  115 \*     18.44                       C~18~H~30~O~3~        294.2198               294.2195                0.9                293.2087\[M − H\]^−^, 275.2009\[M-H-H~2~O\]^−^, 247.2242\[M-H-HCOOH\]^−^, 232.1683\[M-H-H~2~O-C~3~H~7~\]^−^, 152.1063\[M-H-H~2~O-C~9~H~15~\]^−^                                                                       (*E,E*)-9-Oxooctadeca-10,12-dienoic acid                                                                      CML \>\> IML\   \[[@B30-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 2.45\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  116 \*     18.56                       C~18~H~34~O~3~        298.2494               298.2508                −4.6               297.2440\[M − H\]^−^, 279.2478\[M-H-H~2~O\]^−^, 224.1515\[M-H-H~2~O-C~4~H~7~\]^−^, 139.1260\[M-H-C~2~H~5~-C~7~H~13~O~2~\]^−^, 139.1113\[M-H-C~3~H~7~-C~6~H~11~O~2~\]^−^                                               Ricinoleic acid                                                                                               CML \>\> IML\   s
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.12\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  117        19.27                       C~18~H~32~O~3~        296.2339               296.2351                −4.3               295.2266\[M − H\]^−^, 266.1996\[M-H-C~2~H~5~\]^−^, 249.2382\[M-H-HCOOH\]^−^, 184.1156\[M-H-C~8~H~15~\]^−^, 152.1412\[M-H-HCOOH-C~7~H~13~\]^−^, 124.0960\[M-H-H~2~O-C~10~H~17~O\]^−^                                   Coronaric acid                                                                                                CML, IML        \[[@B26-molecules-24-00942]\]

  118        19.71                       C~18~H~34~O~2~        282.2558               282.2559                −0.4               283.2631\[M + H\]^+^, 97.1020\[M + H-C~5~H~11~-C~6~H~11~O~2~\]^+^, 86.1024\[M + H-C~12~H~21~O~2~\]^+^, 72.0876\[M + H-C~13~H~23~O~2~\]^+^                                                                             Oleic acid                                                                                                    CML, IML        s

  119 ^\#^   19.95                       C~21~H~36~O~4~        352.2620               352.2614                1.8                353.2701\[M + H\]^+^, 335.2693\[M + H-H~2~O\]^+^, 214.2202\[M + H-C~3~H~7~O~3~\]^+^, 150.1320\[M + H-C~10~H~19~O~4~\]^+^, 123.1012\[M + H-C~5~H~9~-C~7~H~13~O~4~\]^+^, 83.0715\[M + H-C~7~H~11~-C~8~H~15~O~4~\]^+^    1-Linolenoylglycerol                                                                                          CML \<\< IML\   a
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 5.63\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  120        21.54                       C~18~H~30~O~2~        278.2237               278.2246                −3.0               277.2165\[M − H\]^−^, 182.1234\[M-H-C~7~H~11~\]^−^, 168.1230\[M-H-C~8~H~13~\]^−^, 110.0795\[M-H-C~11~H~17~-H~2~O\]^−^                                                                                                 Linolenic acid                                                                                                CML, IML        s

  121 \*     21.70                       C~15~H~30~O           226.2300               226.2297                1.3                271.2274\[M + HCOO\]^−^, 164.1118\[M-H-C~6~H~13~\]^−^, 108.0499\[M-H-C~10~H~21~\]^−^                                                                                                                                  n-Pentadecanal                                                                                                CML \>\> IML\   \[[@B32-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 4.02\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    

  122 \*     24.46                       C~17~H~34~O           254.2616               254.2610                2.1                299.2594\[M + HCOO\]^−^, 248.2224\[M-H-C~2~H~5~\]^−^, 122.0654\[M-H-C~11~H~23~\]^−^, 94.0506\[M-H-C~13~H~27~\]^−^                                                                                                     n-Heptadecanal                                                                                                CML \>\> IML\   \[[@B32-molecules-24-00942]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     VIP: 3.12\      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *p* \< 0.001    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Characteristic component in CML; ^\#^ characteristic component in IML; ^s^ identified with standard; ^a^ compared with spectral data obtained from Wiley Subscription Services, Inc. (USA); ^b^ compared with NIST Chemistry WebBook.
